Telotristat etiprate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for telotristat etiprate and what is the scope of freedom to operate?
Telotristat etiprate
is the generic ingredient in one branded drug marketed by Tersera and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Telotristat etiprate has seventy patent family members in twenty-nine countries.
Two suppliers are listed for this compound.
Summary for telotristat etiprate
International Patents: | 70 |
US Patents: | 5 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Clinical Trials: | 15 |
Patent Applications: | 101 |
DailyMed Link: | telotristat etiprate at DailyMed |
Recent Clinical Trials for telotristat etiprate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
Barbara Ann Karmanos Cancer Institute | Phase 2 |
Ipsen | Phase 1 |
Pharmacology for telotristat etiprate
Drug Class | Tryptophan Hydroxylase Inhibitor |
Mechanism of Action | Tryptophan Hydroxylase Inhibitors |
US Patents and Regulatory Information for telotristat etiprate
International Patents for telotristat etiprate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 345062 | See Plans and Pricing | |
Japan | 2010540551 | See Plans and Pricing | |
South Korea | 101464391 | See Plans and Pricing | |
Eurasian Patent Organization | 201070410 | ТВЕРДЫЕ ФОРМЫ (S)-ЭТИЛ-2-АМИНО-3-(4-(2-АМИНО-6-((R)-1-(4-ХЛОР-2-(3-МЕТИЛ-1H-ПИРАЗОЛ-1-ИЛ)ФЕНИЛ)-2,2,2-ТРИФТОРЭТОКСИ)ПИРИМИДИН-4-ИЛ)ФЕНИЛ)ПРОПАНОАТА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | See Plans and Pricing |
Denmark | 3176159 | See Plans and Pricing | |
Chile | 2008002880 | (s)-2-amino-3-(4-(2-amino-6-((r-1-(4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2-trifluoroetoxi)pirimidin-4-il)fenil)propanoato de etilo cristalino, sal hipurato y succionato del mismo; metodos de preparacion; forma de dosificacion farmaceutica; y uso para tratar sindrome carcinoide y trastorno gastrointestinal. | See Plans and Pricing |
European Patent Office | 2091940 | COMPOSÉS 4-PHÉNYLE-6-(2,2,2-TRIFLUORO-1-PHÉNYLÉTHOXY) À BASE DE PYRIMIDINE ET PROCÉDÉS CONCERNANT LEUR UTILISATION (4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for telotristat etiprate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2091940 | C02091940/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66374 28.03.2018 |
2091940 | 2018/011 | Ireland | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT OR A PHARMACEUTICALLY ACCEPTABLE ESTER, OR A SALT THEROF, IN PARTICULAR TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL.; REGISTRATION NO/DATE: EU/1/17/1224 20170918 |
2091940 | CA 2018 00011 | Denmark | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT OR A PHARMACEUTICALLY ACCEPTABLE ESTER, OR A SALT THEREOF, INPARTICULAR TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL; REG. NO/DATE: EU/1/17/1224 20170920 |
2091940 | 713 | Finland | See Plans and Pricing | |
2091940 | 11/2018 | Austria | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARER ESTER, ODER EIN SALZ DAVON, INSBESONDERE TELOTRISTATETHYL, INSBESONDERE DAS HIPPURATSALZ VON TELOTRISTATETHYL; REGISTRATION NO/DATE: EU/1/17/1224 (MITTEILUNG) 20170920 |
2091940 | 1890014-2 | Sweden | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT OR A PHARMACEUTICALLY ACCEPTABLE ESTER, OR A SALT THEREOF, IN PARTICULARLY TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL; REG. NO/DATE: EU/1/17/1224 20170920 |
2091940 | CR 2018 00011 | Denmark | See Plans and Pricing | PRODUCT NAME: TELOTRISTAT OR A C1-4 ALKYL ESTER THEREOF, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR TELOTRISTAT ETHYL, MORE PARTICULARLY HIPPURATE SALT OF TELOTRISTAT ETHYL; REG. NO/DATE: EU/1/17/1224 20170920 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.